![Medicine / Clinical medicine / Cancer / Melanoma / RTT / Uveal melanoma / Cancer treatments / Immunology / Oncology / Uvea / Immunocore / Cancer immunotherapy Medicine / Clinical medicine / Cancer / Melanoma / RTT / Uveal melanoma / Cancer treatments / Immunology / Oncology / Uvea / Immunocore / Cancer immunotherapy](https://www.pdfsearch.io/img/a08b8ab67bd73501db5565370b38f386.jpg) Date: 2016-03-29 05:35:06Medicine Clinical medicine Cancer Melanoma RTT Uveal melanoma Cancer treatments Immunology Oncology Uvea Immunocore Cancer immunotherapy | | PRESS RELEASE – IMMUNOCORE LIMITED Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma (Oxford, UK, 30 MarchImmunocore, a world-leading biotechnology company developing novel T cellAdd to Reading ListSource URL: www.immunocore.comDownload Document from Source Website File Size: 413,56 KBShare Document on Facebook
|